DiscGenics Receives FDA Fast Track Designation for Cell Therap...
SALT LAKE CITY, Aug. 27, 2019 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://www.discgenics.com/ ), a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today an...
Authors: LATEST ASIANET NEWS RELEASES